Harrow Health (HROW) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts HROW Hot Sheet
Join SI Premium – FREE
Harrow Health (NASDAQ: HROW) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $33.5 million versus the consensus estimate of $30.34 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ingram Micro Holding Corporation (INGM) Tops Q2 EPS by 4c
- Minerals Technologies (MTX) Misses Q2 EPS by 3c
- Forrester (FORR) Tops Q2 EPS by 11c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
